Prostate cancer remains a significant concern in my practice, which is why I emphasize the importance of early detection. The American Cancer Society estimates there will be nearly 300,000 new cases ...

Sensitivity analyses for radiographic progression-free survival (rPFS): Results from the phase 3 PREVAIL trial comparing enzalutamide to placebo.

The first ever head-to-head comparison of two biomarker tests for grading prostate cancer came out a draw, suggesting that clinicians can use either assessment with confidence, particularly in the ...

THOUSAND MEASLES CASES THIS YEAR. IT’S MEN’S HEALTH MONTH AND IN THE HEADLINES LATELY WITH FORMER PRESIDENT JOE BIDEN’S DIAGNOSIS OF STAGE FOUR PROSTATE CANCER. I SPOKE WITH KOAT HEALTH EXPERT DOCTOR ...

A new 18-gene urine test demonstrated higher diagnostic accuracy for high-grade prostate cancer compared with existing biomarker tests, a study showed. In applying a testing approach with 95% ...